Pharmaceutical
Biopharmaceutical
Biotechnology

ImmunoGen

$2.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-2.32%) Today
+$0.04 (1.58%) After Hours

Why Robinhood?

You can buy or sell ImmunoGen and other stocks, options, ETFs, and crypto commission-free!

About

ImmunoGen, Inc. Common Stock, also called ImmunoGen, is a biotechnology company, which engages in discovering and developing antibody-drug conjugate therapies that meaningfully improve the lives of people with cancer. Read More Its product candidates include Mirvetuximab soravtansine, Coltuximab ravtansine, IMGN7779 and IMGN632. The company was founded in March 1981 and is headquartered in Waltham, MA.

Employees
296
Headquarters
Waltham, Massachusetts
Founded
1981
Market Cap
386.95M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.72M
High Today
$2.59
Low Today
$2.31
Open Price
$2.51
Volume
2.87M
52 Week High
$13.41
52 Week Low
$2.27

Collections

Pharmaceutical
Biopharmaceutical
Biotechnology
Therapy
Cancer Prevention
Technology
Health
US

News

MarketWatch21h

Immunogen Inc. Stock Quote (U.S.: Nasdaq)

Shares of Immunogen Inc. plummeted 48% toward a two-year low in premarket trade Friday, after the company said a phase 3 trial of its ovarian cancer treatment, mirvetuximab soravtansine, compared to chemotherapy, failed to meet its primary endpoint of progression free survival. The company said that based on the efficacy signals, overall response rate and survival, it will conduct additional analysis to evaluation the potential benefit of mirvetuximab soravtansine for FRα-positive platinum-resistant ovarian...

896
Yahoo FinanceMar 12

Options Traders Expect Huge Moves in ImmunoGen (IMGN) Stock

Investors in ImmunoGen, Inc. IMGN need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 3, 2019 $3.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could a...

1,415
Yahoo FinanceMar 10

ImmunoGen (IMGN) Down 50.2% Since Last Earnings Report: Can It Rebound?

ImmunoGen (IMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. It has been about a month since the last earnings report for ImmunoGen (IMGN). Shares have lost about 50.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is ImmunoGen due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most ...

1,542

Earnings

-$0.37
-$0.28
-$0.19
-$0.10
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 3, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.